UNSPSC 51162710: Eprazinone

This classification denotes a mucolytic agent and expectorant with the molecular formula C24H32N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 883YNL63WU, chemically known as 1-propanone, 3-(4-(2-ethoxy-2-phenylethyl)-1-piperazinyl)-2-methyl-1-phenyl- but more generally known as eprazinone, which bears US NIH Compound Identifier 3245. European Medicines Agency schedules Eprazinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06583MIG.

UNSPSC 51162710 Eprazinone, a Commodity code, covers pharmaceutical products and related services that state and local governments procure for correctional healthcare, public health, and emergency-response programs. The code captures injectable pharmaceutical solutions and medical equipment used in institutional settings, including parenteral nutrition preparations, intravenous solutions, and naloxone-based overdose-reversal systems. State and local buyers under this code include departments of corrections, county health agencies, and public-health authorities. The Washington State Department of Corrections (DOC) and Seminole County, Florida represent the issuing bodies active in recent opportunities, each procuring specific pharmaceutical products to support medically necessary care for incarcerated populations and community health initiatives.

Recent activity spans Washington and Florida. The Washington State DOC issued RFQ QK13020 on September 8, 2026, with quotes due October 7, 2026, seeking parenteral products and services for eight correctional facilities across three regions (West, Central, and East), with delivery windows as tight as 24 hours for parenteral nutrition bags and 8 hours for other parenteral products; the DOC anticipates selecting up to three contractors per region and requires demonstrated experience in IV solution preparation, patient lab monitoring, and parenteral nutrition adjustments. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building in Sanford, with a two-year initial term and one-year renewal option. Both opportunities emphasize vendor compliance with insurance requirements, business licensing, and state-level set-aside or diversity participation goals where applicable.